9 of 18 patients in a small study experienced regression of precancerous cell changes that can lead to cervical cancer.
Kevin Manno is optimistic about his prognosis and will undergo surgery next month to remove a part or all of his thyroid.
The antibody-drug conjugate improved progression-free survival for patients previously treated with hormone therapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback